Skip to main content
. 2015 Apr 28;170(4):496–503. doi: 10.1111/bjh.13456

Figure 2.

Figure 2

MCL‐001 exploratory analysis of Ki‐67 expression and response following lenalidomide in patients with relapsed/refractory MCL: response rates at (A) 30% and (B) 50% cut‐off thresholds. CR/CRu, complete response/CR unconfirmed; ORR, overall response rate; PR, partial response; and SD, stable disease.